← Back to headlines
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
Goldman Sachs has reaffirmed its 'Buy' rating for Abbott Laboratories (ABT) stock, indicating continued confidence in the healthcare company's investment potential.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
